Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Dec 14, 2020 11:14am
183 Views
Post# 32099584

RE:Newswire Dec 14 2020- AGM

RE:Newswire Dec 14 2020- AGM


Toronto, Ontario – TheNewswire – December 14, 2020 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; ( OTC:VPTDF) announces it has received an interest-free loan for $163,000 from the Federal Economic Development Agency for Southern Ontario Regional Relief and Recovery Fund . The loan is to be used to assist the Company in meeting its financial obligations related to fixed operating costs. The loan is repayable starting in April 2023 in equal monthly installments over a 5-year period with the final payment in 2028.

The Company has continued to receive other grants, loans and subsidies and so the total amount of government support has been approximately $460,000 to date in 2020.

In other news, the Company wishes to remind its shareholders of the Annual General and Special meeting being held virtually today at 11:00 am EST. The meeting can be accessed at https://global.gotomeeting.com/join/788626925 .

<< Previous
Bullboard Posts
Next >>